MEG3 decreased the cell migration and invasion of NSCLC PC9 and H1299 cells via suppressing miR-21-5p, resulting in elevated PTEN expression levels, partially via the PI3k/Akt pathway [68]. The gene discussed is MEG3; the disease is non-small cell lung carcinoma.